American Century Companies Inc. raised its stake in West Pharmaceutical Services, Inc. (NYSE:WST) by 0.4% during the second quarter, according to its most recent filing with the SEC. The fund owned 701,364 shares of the medical instruments supplier’s stock after buying an additional 2,605 shares during the period. American Century Companies Inc. owned about 0.95% of West Pharmaceutical Services worth $66,293,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of the company. Harfst & Associates Inc. acquired a new stake in shares of West Pharmaceutical Services during the first quarter valued at approximately $186,000. Tyers Asset Management LLC boosted its stake in shares of West Pharmaceutical Services by 17.6% in the first quarter. Tyers Asset Management LLC now owns 2,464 shares of the medical instruments supplier’s stock valued at $201,000 after buying an additional 368 shares during the period. Cambridge Investment Research Advisors Inc. boosted its stake in shares of West Pharmaceutical Services by 1.6% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 2,569 shares of the medical instruments supplier’s stock valued at $210,000 after buying an additional 40 shares during the period. CIBC Asset Management Inc acquired a new stake in shares of West Pharmaceutical Services during the second quarter valued at approximately $223,000. Finally, Koch Industries Inc. acquired a new stake in shares of West Pharmaceutical Services during the first quarter valued at approximately $225,000. 91.32% of the stock is currently owned by hedge funds and other institutional investors.

Shares of West Pharmaceutical Services, Inc. (WST) opened at 84.70 on Tuesday. The company has a market capitalization of $6.27 billion, a PE ratio of 36.35 and a beta of 1.10. The stock has a 50 day moving average of $89.34 and a 200-day moving average of $88.85. West Pharmaceutical Services, Inc. has a one year low of $70.17 and a one year high of $99.91.

West Pharmaceutical Services (NYSE:WST) last posted its earnings results on Thursday, July 27th. The medical instruments supplier reported $0.66 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.01. The business had revenue of $397.60 million for the quarter, compared to analysts’ expectations of $406 million. West Pharmaceutical Services had a net margin of 11.42% and a return on equity of 14.02%. The business’s revenue for the quarter was up 2.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.59 EPS. On average, equities analysts forecast that West Pharmaceutical Services, Inc. will post $2.69 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, November 1st. Shareholders of record on Wednesday, October 18th will be paid a dividend of $0.14 per share. The ex-dividend date of this dividend is Tuesday, October 17th. This represents a $0.56 annualized dividend and a yield of 0.66%. This is a boost from West Pharmaceutical Services’s previous quarterly dividend of $0.13. West Pharmaceutical Services’s dividend payout ratio is currently 22.22%.

TRADEMARK VIOLATION NOTICE: “American Century Companies Inc. Has $66.29 Million Stake in West Pharmaceutical Services, Inc. (WST)” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright law. The correct version of this report can be accessed at https://www.thecerbatgem.com/2017/08/29/american-century-companies-inc-has-66-29-million-stake-in-west-pharmaceutical-services-inc-wst.html.

WST has been the topic of several analyst reports. BidaskClub cut shares of West Pharmaceutical Services from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 13th. Zacks Investment Research raised shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and set a $108.00 target price on the stock in a report on Saturday, June 17th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and issued a $90.00 target price on shares of West Pharmaceutical Services in a report on Thursday, June 8th. Two analysts have rated the stock with a sell rating, one has given a hold rating and two have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $90.18.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Stock Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related stocks with our FREE daily email newsletter.